Dr. Marc Harrison, previously CEO of Intermountain Healthcare, joined venture firm General Catalyst, marking a unique shift from healthcare to venture capital. General Catalyst’s acquisition of Summa Health, a non-profit integrated health system, signals its venture into transforming traditional healthcare systems into tech-enabled, for-profit entities. Harrison now leads the Health Assurance Transformation Corporation (HATCo), focusing… Continue reading Venture capital firm’s plan to buy nonprofit hospital system has Ohio community on edge

Viking Therapeutics emerges as a strong contender in the weight loss drug market, with its experimental obesity treatment showing promising results. The company’s shares surged 120% after data from a midstage trial indicated significant weight loss potential, positioning Viking as a key player in a market estimated to reach $100 billion by the end of… Continue reading Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

Recent changes in Medicaid programs aimed at bridging the health coverage gap in the U.S. have inadvertently left some Americans, particularly people of color, without adequate coverage. While the insured rates among the non-elderly population increased during the Covid-19 pandemic, with approximately 3.4 million Americans enrolling in health coverage between 2019 and 2022, disparities persisted,… Continue reading Medicaid challenges leave many Black Americans uninsured

Alpha Cognition, Inc. (CSE: ACOG)(OTCQB: ACOGF), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced that Michael McFadden, Chief Executive Officer, and Lauren D’Angelo, Chief Operating Officer, will present live at the Life Science Investor Forum, hosted by VirtualInvestorConferences.com, on March 7th,… Continue reading Alpha Cognition to Present at the Life Science Investor Forum March 7th

Pfizer’s vaccine, Abrysvo, designed to combat respiratory syncytial virus (RSV), has demonstrated sustained effectiveness in protecting older adults over the course of two full RSV seasons, as announced by the company. While the efficacy of the vaccine showed a slight decline compared to its initial levels after one season, it remains robust for individuals aged… Continue reading Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

The landscape of weight loss treatments is evolving with the emergence of new drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, but their efficacy comes with a caveat: they should complement rather than replace diet and exercise programs, as mandated by the FDA. This directive poses a fundamental question for WeightWatchers (WW): is it… Continue reading Oprah Winfrey is leaving WeightWatchers board and giving away all her stock at critical weight loss moment

Novavax faced a significant drop in shares, declining by over 20% after reporting fourth-quarter revenue and earnings that fell short of Wall Street expectations and predicting flat or decreased full-year 2024 sales. Despite narrowing losses compared to the previous year, the biotech company’s Covid vaccine demand decreased amid declining global demand for Covid-related products. In… Continue reading Novavax stock falls 20% as vaccine maker misses quarterly estimates, sees sluggish 2024 sales

The article discusses the implications of new weight loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, which are required by the FDA to be prescribed alongside diet and exercise programs, rather than as standalone treatments for obesity. With more drugs entering the market and insurers starting to cover them, there’s debate over whether… Continue reading Thinking about taking new weight loss drugs? These are the big health risk decisions that will follow

Honor, the Chinese electronics manufacturer, is venturing into the realm of wearable technology with the development of its own smart ring, as revealed by CEO George Zhao during the Mobile World Congress in Barcelona. This announcement comes hot on the heels of Samsung’s unveiling of its Galaxy Ring, designed to track health metrics like heart… Continue reading Huawei spinoff Honor developing a smart ring after Samsung debuts its own wearable

Shares of Viking Therapeutics surged more than 90% following promising initial results from its experimental weight loss drug in a mid-stage trial. As part of a burgeoning weight loss drug industry projected to reach $100 billion by the decade’s end, Viking Therapeutics has attracted attention, with analysts speculating about potential acquisition by larger pharmaceutical firms… Continue reading Viking Therapeutics stock jumps 90% after positive weight loss drug trial results

Highmark Health has unveiled plans to leverage technology from Google Cloud and healthcare software company Epic Systems in a bid to enhance data gathering for healthcare providers and payers. The initiative addresses the challenge of fragmented healthcare data storage across various systems and formats in the U.S., which often complicates access for stakeholders. By combining… Continue reading Highmark Health says it’s combining tech from Google and Epic to give doctors easier access to information

Zealand Pharma’s stock witnessed a dramatic surge following the announcement of promising results from a Phase 2 trial of its liver disease treatment, survodutide. The trial revealed that 83% of adults with a form of liver inflammation caused by excess fat cells, known as “MASH,” experienced positive outcomes. This efficacy has sparked enthusiasm among investors… Continue reading Novo Nordisk and Eli Lilly rival soars 32% after promising weight loss drug results